S M Goldinger
An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel
Thurneysen S, Levesque M, Mangana J, Goldinger S, Guenova E, Ziegler M, Nägeli M, Jaberg-Bentele N, Kunz M, Nagel H, Cheng P, Dummer R. An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel. Br J Dermatol 2016
May 11, 2016An exploratory study investigating the metabolic activity and local cytokine profile in melanoma patients treated with pazopanib and paclitaxel
May 11, 2016Br J Dermatol 2016
Thurneysen S, Levesque M P, Mangana J, Goldinger S M, Guenova Emmanuella, Ziegler M, Nägeli M, Jaberg-Bentele N, Kunz M, Nagel H W, Cheng P F, Dummer R
Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study
Kunz M, French L, Kamarachev J, Guenova E, Cozzio A, Dippel M, Jenni D, Mangana J, Belloni B, Dreier J, Frauchiger A, Goldinger S, Urosevic-Maiwald M, Dummer R. Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study. J Eur Acad Dermatol Venereol 2015; 30:293-8.
Oct 27, 2015Efficacy and safety of oral alitretinoin in severe oral lichen planus--results of a prospective pilot study
Oct 27, 2015J Eur Acad Dermatol Venereol 2015; 30:293-8
Kunz M, French L E, Kamarachev J, Guenova Emmanuella, Cozzio A, Dippel M, Jenni D, Mangana J, Belloni B, Dreier J, Frauchiger A L, Goldinger S M, Urosevic-Maiwald M, Dummer R
First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK). First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07). Ann Oncol 2011; 23:531-6.
Apr 28, 2011First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)
Apr 28, 2011Ann Oncol 2011; 23:531-6
von Moos R, Dummer R, Schönewolf N, Mamot C, Mjhic-Probst D, Schraml P H, Moch H, Schläppi M, Cathomas R, Michielin O, Ochsenbein A, Gillessen S, Goldinger S M, Simcock M, Seifert B, on behaalf of the Swiss Group for Clinical Cancer Research (SAKK)